Clinical evaluation
A healthcare professional reviews symptoms, smoking history, exposure history, previous lung disease, family history and physical examination findings.
Lung Cancer Education · Diagnosis · Staging · Biomarker Testing
Lung Cancer Diagnosis & Staging
Lung cancer diagnosis and staging are step-by-step clinical processes used to confirm whether cancer is present, identify the tumor type, evaluate how far it has spread and guide further medical decision-making.
Educational information only. This page does not provide diagnosis, treatment
recommendations or medical advice.
CT
PET
Biopsy
TNM
What does lung cancer diagnosis involve?
Diagnosis usually begins when symptoms, screening results or imaging findings suggest a possible lung abnormality. Doctors may use imaging, tissue sampling, pathology and molecular tests to confirm the diagnosis and classify the disease.
Imaging tests
Chest X-ray, CT scan, PET/CT, MRI or other imaging studies may be used to locate suspicious lesions and evaluate possible spread.
Tissue confirmation
A biopsy can provide tissue or cells for pathology review, helping confirm cancer type and distinguish NSCLC, SCLC or other lung diseases.
Lung cancer diagnosis process
The exact pathway depends on the person, symptoms, imaging findings and clinical situation. The following steps are commonly discussed in lung cancer evaluation.
1
Medical history and physical examination
Symptoms, risk factors and general health are reviewed. This helps determine which diagnostic tests may be appropriate.
2
Chest imaging
Imaging can identify lung nodules, masses, lymph node enlargement, fluid around the lung or signs that cancer may have spread.
3
Bronchoscopy or needle biopsy
Tissue may be collected using bronchoscopy, CT-guided needle biopsy, endobronchial ultrasound-guided biopsy or another specialist procedure.
4
Pathology review
Pathologists examine tumor cells to determine whether the cancer is NSCLC, SCLC or another type. Histology may include adenocarcinoma, squamous cell carcinoma or other subtypes.
5
Molecular and biomarker testing
Testing may evaluate markers such as EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, NTRK, HER2 and PD-L1, depending on tumor type and clinical context.
Common tests used in lung cancer diagnosis
Diagnostic tests help locate suspicious tissue, confirm whether cancer is present and collect information needed for classification and staging.
Chest X-ray
May show a mass, fluid, collapse or other lung changes, but CT is usually more detailed.
CT scan
Provides detailed cross-sectional images of the chest and can help evaluate tumor location and lymph nodes.
PET/CT scan
Can help identify metabolically active disease and evaluate possible spread to lymph nodes or distant organs.
Bronchoscopy
Uses a flexible scope to examine the airways and collect tissue or fluid samples when appropriate.
Needle biopsy
Collects tissue from a suspicious lung lesion or lymph node, often guided by CT or ultrasound.
Pathology testing
Determines tumor type, histology and other microscopic features needed for diagnosis.
Molecular testing
Looks for genetic alterations or biomarkers that help characterize tumor biology.
Brain MRI
May be used during staging to evaluate whether cancer has spread to the brain in selected cases.
What is lung cancer staging?
Staging describes the extent of cancer in the body. It considers the size and location of the primary tumor, whether nearby lymph nodes are involved and whether cancer has spread to distant organs.
T
Tumor
Describes the size and local extent of the primary lung tumor.
N
Nodes
Describes whether cancer has spread to nearby lymph nodes.
M
Metastasis
Describes whether cancer has spread to distant organs or tissues.
TNM
Tumor size
Lymph nodes
Metastasis
Stage group
NSCLC stage groups
Non-small cell lung cancer is commonly grouped from earlier to more advanced stages. The exact stage depends on detailed TNM findings and specialist review.
Stage 0
Abnormal cells are found in the lining of the airways and have not invaded deeper tissues.
Stage I
Cancer is generally limited to the lung and has not spread to lymph nodes.
Stage II
Cancer may be larger or may involve nearby lymph nodes within the lung region.
Stage III
Cancer has usually spread to lymph nodes in the chest or nearby structures.
Stage IV
Cancer has spread to distant organs, the opposite lung, fluid around the lung or other distant sites.
Small cell lung cancer staging
Small cell lung cancer may be described using limited-stage and extensive-stage categories. In some settings, TNM stage grouping is also used.
Limited-stage SCLC
Cancer is generally confined to one side of the chest and can often be included within a single radiation treatment field, depending on specialist assessment.
Extensive-stage SCLC
Cancer has spread more widely in the chest or to distant parts of the body, such as the liver, bones, brain or opposite lung.
Why diagnosis and staging matter
Diagnosis confirms the type of lung cancer. Staging defines the extent of disease. Together, these results help clinicians evaluate prognosis, select additional tests and plan individualized care.
Diagnosis + Stage + Biomarkers = clearer clinical picture
Biomarker testing in lung cancer
Biomarker and molecular testing can help characterize tumor biology. These tests are especially important in many non-small cell lung cancer cases.
EGFR
Mutation testing may identify altered growth factor receptor signaling.
ALK
Fusion or rearrangement testing can define a specific molecular subtype.
KRAS
KRAS alterations are studied in oncogenic signaling and tumor progression.
ROS1
ROS1 rearrangements are another molecular feature studied in lung cancer.
MET / RET / NTRK
Alterations in these genes may be evaluated in expanded molecular profiling.
PD-L1
Expression testing helps describe immune checkpoint biology in tumor tissue.
FAQ: Lung Cancer Diagnosis & Staging
Clear answers to common questions about lung cancer testing, biopsy, imaging and stage classification.
How is lung cancer diagnosed?
Lung cancer is diagnosed using a combination of clinical evaluation, imaging, tissue sampling, pathology review and sometimes molecular or biomarker testing.
Is a biopsy needed to confirm lung cancer?
In many cases, tissue or cell sampling is needed to confirm the diagnosis and identify the cancer type. The exact procedure depends on tumor location and clinical assessment.
What does lung cancer staging mean?
Staging describes how much cancer is present and whether it has spread to lymph nodes or distant organs. It helps guide medical planning.
What is TNM staging?
TNM staging describes the primary tumor, lymph node involvement and distant metastasis. These findings are combined to assign a stage group.
What is the difference between NSCLC and SCLC staging?
NSCLC is commonly staged from 0 to IV using TNM-based stage groups. SCLC is often described as limited-stage or extensive-stage, although TNM staging may also be used.
Is this page medical advice?
No. This page is for educational information only and does not replace consultation with a qualified healthcare professional.
Scientific References
Authoritative sources used to support lung cancer diagnosis and staging content.
- National Cancer Institute. Non-Small Cell Lung Cancer Treatment PDQ: diagnosis and staging information.
- American Cancer Society. Lung Cancer Early Detection, Diagnosis, and Staging.
- American Cancer Society. How Is Lung Cancer Diagnosed?
- NICE Guideline NG122. Lung cancer: diagnosis and staging.
- American Lung Association. Lung Cancer Staging.